Scancell Holding plc

Company Information

Address:

Hucknall Road
Nottingham
NG5 1PB

Tel:

020 7245 1100

Fax:

E-Mail:

Secretary:

N Evans

Registrar:

Company Overview

Scancell is developing novel therapeutic vaccines for the treatment of cancer and infectious diseases. Scancell’s first cancer vaccine SCIB1 is being developed for the treatment of melanoma and is in Phase I clinical trials.

Annual Reports

Description Report Date Published
Annual Report 201130-04-201130-06-2011
Annual Report 201030-04-201013-07-2010
Annual Report 200930-04-200901-01-1970

Interim Reports

Description Report Date Published
Interim Report 201031-10-201031-01-2011
Interim Report 200931-10-200929-01-2010

Dividend Histroy

Type Dividend Payment Date
A B C D E F G
H I J K L M
N O P Q R S T
U V W X Y Z #